Arcturus Therapeutics Holdings Inc. Common Stock
ARCT US03969T1097
💰
Capitalization
Small-cap
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
🔗
Website
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4203% | -22% | -44% | 8098% | -7% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
📊
Transactions
9
🙍
Insiders
2
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Sassine Andy CFO |
16.56 USD |
1,238 Sold |
20,499 USD |
15/08/2025 | 15/08/2025 |
| Sassine Andy CFO |
16.56 USD |
1,238 Bought |
20,499 USD |
15/08/2025 | 15/08/2025 |
| Chivukula Pad SR OFF |
20.76 USD |
12,000 Sold |
249,121 USD |
15/10/2024 | 15/10/2024 |
| Sassine Andy CFO |
32.03 USD |
50,000 Sold |
1,601,500 USD |
12/06/2024 | 12/06/2024 |
| Chivukula Pad SR OFF |
45.00 USD |
114 Sold |
5,130 USD |
05/06/2024 | 05/06/2024 |
| Chivukula Pad SR OFF |
40.01 USD |
26,000 Sold |
1,040,234 USD |
03/06/2024 | 03/06/2024 |
| Chivukula Pad SR OFF |
35.02 USD |
17,435 Sold |
610,574 USD |
25/03/2024 | 25/03/2024 |
| Chivukula Pad SR OFF |
35.01 USD |
8,565 Sold |
299,839 USD |
19/03/2024 | 19/03/2024 |
| Chivukula Pad SR OFF |
18.72 USD |
5,000 Sold |
93,602 USD |
01/11/2023 | 01/11/2023 |